Concepedia

Shuku Kubo

SK

6

Publications

542

Citations

6

H-Index

2008

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Shuku Kubo is an author at Daiichi-Sankyo (Japan) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2008–2016

6

Publications

6

CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity

Makoto Yamashita, Takanori Tomozawa, Masayo Kakuta et al. · Antimicrobial Agents and Chemotherapy · 2008 · 213 citations · Full text

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration

Shuku Kubo, Takanori Tomozawa, Masayo Kakuta et al. · Antimicrobial Agents and Chemotherapy · 2010 · 126 citations · Full text

Efficacy of the New Neuraminidase Inhibitor CS-8958 against H5N1 Influenza Viruses

Maki Kiso, Shuku Kubo, Makoto Ozawa et al. · PLoS Pathogens · 2010 · 84 citations · Full text

A novel sphingomyelin/cholesterol domain‐specific probe reveals the dynamics of the membrane domains during virus release and in Niemann‐Pick type C

Asami Makino, Mitsuhiro Abe, Reiko Ishitsuka et al. · The FASEB Journal · 2016 · 49 citations · Full text

Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en

Takeshi Honda, Shuku Kubo, Takeshi Masuda et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations

, , +5

Rows per page

1–5 of 6